Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Spyre Therapeutics Inc. buy BiotechBee

Spyre Therapeutics Inc.
Start price
€84.50
03.08.26 / 80%
Target price
€150.00
30.09.28
Performance (%)
5.33%
Price
?
08:33
Summary
This prediction is currently active. The BUY prediction by BiotechBee shows slight gains of 5.33%. This prediction currently runs until 30.09.28. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 80% into this prediction
Performance without dividends (%)
Name 1w
Spyre Therapeutics Inc. -3.297%
iShares Core DAX® -0,05 %
iShares Nasdaq 100 0,92 %
iShares Nikkei 225® 3,01 %
iShares S&P 500 -0,36 %

According to BiotechBee what are the pros and cons of Spyre Therapeutics Inc. for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Spyre Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) 5.33%
Target price 150.000
Change
Ends at 30.09.28

Buy mit Kursziel 150,0

BiotechBee 
0
Report Share
03.08.26